The SPOCK1-MMP-2 axis is related to a worse prognosis and can be considered as a specific biomarker for the prediction of EMT-regulated invasion of ccRCC cells, as well as a possible therapeutic target [137]. This evidence concerns the gene SPOCK1 and nonpapillary renal cell carcinoma.